Applications of nanomaterials in the diagnosis and treatment of thyroid disorders

Abstract

Thyroid diseases, encompassing both thyroid dysfunction and benign or malignant thyroid nodules, are among the most prevalent disorders within the endocrine system. However, in some cases, current diagnostic approaches for different thyroid diseases lack precision, and therapeutic strategies for advanced tumors remain suboptimal in terms of efficacy. The recent emergence of nanomaterials and collagen have introduced novel paradigms for advancing the clinical diagnosis and management of thyroid disorders. Nanomaterials engineered with tailored designs enable exceptional precision in lesion targeting and ultra-sensitive detection of serum biomarkers. Furthermore, their superior biocompatibility and robust stability have been harnessed to optimize targeted drug delivery and controlled release systems, thereby enhancing therapeutic value while minimizing off-target damage to healthy tissues. As a primary constituent of the natural extracellular matrix, collagen serves as an innate biopolymer nanomaterial. Its nanostructured forms (including fibers, particles, and hydrogels) demonstrate extensive biomedical applicability, facilitating thyroid cell adhesion and functional regeneration while offering an optimal substrate for implantable diagnostic and therapeutic devices. This review highlights nanomaterials’ diagnostic/therapeutic advancements for thyroid diseases, discusses clinical challenges, and outlines future directions. Collagen, beyond being a nanomaterial adjunct, shows standalone promise in regenerative medicine, potentially enabling novel precision approaches.

Keywords

Nanomaterials / Collagen / Thyroid dysfunction / Thyroid cancer / Diagnosis / Therapeutics

References

[1] Cohen B, Cadesky A, Jaggi S. Dermatologic manifestations of thyroid disease: a literature review. Front Endocrinol, 2023, 14 1167890

[2] Fernández-García V, González-Ramos S, Martín-Sanz P, Laparra JM, Boscá L. Beyond classic concepts in thyroid homeostasis: immune system and microbiota. Mol Cell Endocrinol, 2021, 533 111333

[3] Ross I, Omengan DB, Huang GN, Payumo AY. Thyroid hormone-dependent regulation of metabolism and heart regeneration. J Endocrinol, 2022, 252(3): R71-R82

[4] Soares De Oliveira L, Ritter MJ. Thyroid hormone and the liver. Hepatol Commun, 2024, 9(1 e0596

[5] Sinha RA, Yen PM. Metabolic messengers: thyroid hormones. Nat Metab, 2024, 64): 639-50

[6] Lyu Z, Zhang Y, Sheng C, Huang Y, Zhang Q, Chen K. Global burden of thyroid cancer in 2022: incidence and mortality estimates from GLOBOCAN. Chin Med J, 2024, 137(21): 2567-76

[7] Zhang X, Wang X, Hu H, Qu H, Xu Y, Li Q. Prevalence and trends of thyroid disease among adults, 1999–2018. Endocr Pract, 2023, 29(11): 875-80

[8] Wang K, Yang X, Xiao Y, Cao Z, Zhang S, Zhang Pet al.. Simultaneous identification of major thyroid hormones by a nickel immobilized biological nanopore. Nano Lett, 2024, 24(1): 305-11

[9] Van Uytfanghe K, Ehrenkranz J, Halsall D, Hoff K, Loh TP, Spencer CAet al.. Thyroid stimulating hormone and thyroid hormones (triiodothyronine and thyroxine): an American Thyroid Association-commissioned review of current clinical and laboratory status. Thyroid®, 2023, 33(9): 1013-28

[10] Grani G, Sponziello M, Filetti S, Durante C. Thyroid nodules: diagnosis and management. Nat Rev Endocrinol, 2024, 20(12): 715-28

[11] Weng Q, Hu X, Zheng J, Xia F, Wang N, Liao Het al.. Toxicological risk assessments of iron oxide nanocluster- and gadolinium-based T1MRI contrast agents in renal failure rats. ACS Nano, 2019, 13(6): 6801-12

[12] Bettmann MA. Frequently asked questions: iodinated contrast agents. Radiographics, 2004, 24(Suppl 1): S3-S10

[13] Kahaly GJ, Gottwald-Hostalek U. Use of levothyroxine in the management of hypothyroidism: a historical perspective. Front Endocrinol, 2022, 13 1054983

[14] Alhassan AA, Alidrisi HA, Mansour AA. Validity of the rapid thyroxine absorption test for the differentiation between levothyroxine non-compliance and malabsorption in thyroid-stimulating hormone refractory hypothyroidism. Cureus, 2023, 15(4): e37776

[15] Mateo RCI, Hennessey JV. Thyroxine and treatment of hypothyroidism: seven decades of experience. Endocrine, 2019, 66110-7

[16] Ruslan A, Okosieme OE. Non-thionamide antithyroid drug options in Graves’ hyperthyroidism. Expert Rev Endocrinol Metab, 2023, 18(1): 67-79

[17] Raffaelli M, Voloudakis N, Barczynski M, Brauckhoff K, Durante C, Gomez-Ramirez Jet al.. European society of endocrine surgeons (ESES) consensus statement on advanced thyroid cancer: definitions and management. Br J Surg, 2024, 111(8 znae199

[18] Shen H, Zhu R, Liu Y, Hong Y, Ge J, Xuan Jet al.. Radioiodine-refractory differentiated thyroid cancer: molecular mechanisms and therapeutic strategies for radioiodine resistance. Drug Resist Updat, 2024, 72 101013

[19] Pugazhendhi A, Edison TNJI, Velmurugan BK, Jacob JA, Karuppusamy I. Toxicity of doxorubicin (Dox) to different experimental organ systems. Life Sci, 2018, 200: 26-30

[20] Feng G, Luo Y, Zhang Q, Zeng F, Xu J, Zhu J. Sorafenib and radioiodine-refractory differentiated thyroid cancer (RR-DTC): a systematic review and meta-analysis. Endocrine, 2020, 681): 56-63

[21] Shyam Sunder S, Sharma UC, Pokharel S. Adverse effects of tyrosine kinase inhibitors in cancer therapy: pathophysiology, mechanisms and clinical management. Signal Transduct Target Ther, 2023, 8(1 262

[22] Yan Y, Cai H, Yang M. The application of nanotechnology for the diagnosis and treatment of endocrine disorders: a review of current trends, toxicology and future perspective. Int J Nanomedicine, 2024, 19: 9921-42

[23] Liu L, Yang M, Chen Z. Surface functionalized nanomaterial systems for targeted therapy of endocrine related tumors: a review of recent advancements. Drug Deliv, 2024, 311 2390022

[24] Liu J, Li B, Li L, Ming X, Xu ZP. Advances in nanomaterials for immunotherapeutic improvement of cancer chemotherapy. Small, 2024, 2038): e2403024

[25] Kang Y, Li S. Nanomaterials: breaking through the bottleneck of tumor immunotherapy. Int J Biol Macromol, 2023, 230 123159

[26] Rahman MA, Jalouli M, Yadab MK, Al-Zharani M. Progress in drug delivery systems based on nanoparticles for improved glioblastoma therapy: addressing challenges and investigating opportunities. Cancers, 2025, 174 701

[27] Razzaq S, Fatima I, Moafian Z, Rahdar A, Fathi-Karkan S, Kharaba Zet al.. Nanomedicine innovations in colon and rectal cancer: advances in targeted drug and gene delivery systems. Med Oncol, 2025, 424 113

[28] Almenara-Fuentes L, Rodriguez-Fernandez S, Rosell-Mases E, Kachler K, You A, Salvado Met al.. A new platform for autoimmune diseases. Inducing tolerance with liposomes encapsulating autoantigens. Nanomed Nanotechnol Biol Med, 2023, 48 102635

[29] Alshamrani M. Broad-spectrum theranostics and biomedical application of functionalized nanomaterials. Polymers, 2022, 146 1221

[30] Zhang S, Gao H, Bao G. Physical principles of nanoparticle cellular endocytosis. ACS Nano, 2015, 998655-71

[31] Hu Q, Zuo H, Hsu JC, Zeng C, Tian Z, Sun Z, Cai W, Tang Z, Chen W. The emerging landscape for combating resistance associated with energy-based therapies via nanomedicine. Adv Mater, 2024, 36(5): e2308286

[32] Shoulders MD, Raines RT. Collagen structure and stability. Annu Rev Biochem, 2009, 78: 929-58

[33] Zheng M, Wang X, Chen Y, Yue O, Bai Z, Cui B, Jiang H, Liu X. A review of recent progress on collagen-based biomaterials. Adv Healthc Mater, 2023, 12(16): e2202042

[34] Rømer AMA, Thorseth ML, Madsen DH. Immune modulatory properties of collagen in cancer. Front Immunol, 2021, 12 791453

[35] Wang Y, Wang Z, Dong Y. Collagen-based biomaterials for tissue engineering. ACS Biomater Sci Eng, 2023, 931132-50

[36] Xie F, Yan L, Li YM, Lan Y, Xiao J, Zhang MBet al.. Targeting diagnosis of high-risk papillary thyroid carcinoma using ultrasound contrast agent with the BRAF^V600E mutation: an experimental study. J Ultrasound Med, 2022, 41(11): 2789-802

[37] Namen AV, Jandhyala S, Jordan T, Luke GP. Repeated acoustic vaporization of perfluorohexane nanodroplets for contrast-enhanced ultrasound imaging. IEEE Trans Ultrason Ferroelectr Freq Control, 2021, 68(12): 3497-506

[38] Peng C, Zheng L, Chen Q, Shen M, Guo R, Wang Het al.. PEGylated dendrimer-entrapped gold nanoparticles for in vivo blood pool and tumor imaging by computed tomography. Biomaterials, 2012, 33(4): 1107-19

[39] Bobo D, Robinson KJ, Islam J, Thurecht KJ, Corrie SR. Nanoparticle-based medicines: a review of FDA-approved materials and clinical trials to date. Pharm Res, 2016, 33(10): 2373-87

[40] Kong N, Ji X, Wang J, Sun X, Chen G, Fan Tet al.. Ros-mediated selective killing effect of black phosphorus: mechanistic understanding and its guidance for safe biomedical applications. Nano Lett, 2020, 20(5): 3943-55

[41] Lai J, Luo Z, Chen L, Wu Z. Advances in nanotechnology-based targeted-contrast agents for computed tomography and magnetic resonance. Sci Prog, 2024, 107(1): 368504241228076

[42] Chen X, Zhu H, Huang X, Wang P, Zhang F, Li Wet al.. Novel iodinated gold nanoclusters for precise diagnosis of thyroid cancer. Nanoscale, 2017, 962219-31

[43] Giovanella L, Avram AM, Iakovou I, Kwak J, Lawson SA, Lulaj Eet al.. EANM practice guideline/SNMMI procedure standard for RAIU and thyroid scintigraphy. Eur J Nucl Med Mol Imaging, 2019, 46(12): 2514-25

[44] Atchudan R, Chandra Kishore S, Gangadaran P, Jebakumar Immanuel Edison TN, Perumal S, Rajendran RLet al.. Tunable fluorescent carbon dots from biowaste as fluorescence ink and imaging human normal and cancer cells. Environ Res, 2022, 204(Pt D 112365

[45] Liu J, Xu C, Wang R, Han P, Zhao Q, Li Het al.. Do carbon nanoparticles really improve thyroid cancer surgery? A retrospective analysis of real-world data. World J Surg Oncol, 2020, 181 84

[46] Rajendran RL, Paudel S, Gangadaran P, Oh JM, Oh EJ, Hong CMet al.. Extracellular vesicles act as nano-transporters of tyrosine kinase inhibitors to revert iodine avidity in thyroid cancer. Pharmaceutics, 2021, 132 248

[47] Xu K, Wu X. Recent development on nanomaterial-based biosensors for identifying thyroid tumor biomarkers. Biotechnol Appl Biochem, 2024, 716): 1329-38

[48] Huang R, Zhou X, Chen G, Su L, Liu Z, Zhou Pet al.. Advances of functional nanomaterials for magnetic resonance imaging and biomedical engineering applications. WIREs Nanomed Nanobiotechnol, 2022, 14(4 e1800

[49] Alphandéry E. Nanomaterials as ultrasound theragnostic tools for heart disease treatment/diagnosis. Int J Mol Sci, 2022, 233 1683

[50] Pellico J, Gawne PJ, de Rosales TM. Radiolabelling of nanomaterials for medical imaging and therapy. Chem Soc Rev, 2021, 505): 3355-3423

[51] Lammers T. Improving the efficacy of combined modality anticancer therapy using HPMA copolymer-based nanomedicine formulations. Adv Drug Deliv Rev, 2010, 62(2): 203-30

[52] Beniwal N, Verma A, Putta CL, Rengan AK. Recent trends in bio-nanomaterials and non-invasive combinatorial approaches of photothermal therapy against cancer. Nanotheranostics, 2024, 8(2): 219-38

[53] Kwiatkowski S, Knap B, Przystupski D, Saczko J, Kędzierska E, Knap-Czop Ket al.. Photodynamic therapy - mechanisms, photosensitizers and combinations. Biomed Pharmacother, 2018, 106: 1098-107

[54] Son S, Kim JH, Wang X, Zhang C, Yoon SA, Shin Jet al.. Multifunctional sonosensitizers in sonodynamic cancer therapy. Chem Soc Rev, 2020, 49(11): 3244-61

[55] Sabuncu S, Javier Ramirez R, Fischer JM, Civitci F, Yildirim A. Ultrafast background-free ultrasound imaging using blinking nanoparticles. Nano Lett, 2023, 23(2): 659-66

[56] Shapiro MG, Goodwill PW, Neogy A, Yin M, Foster FS, Schaffer DVet al.. Biogenic gas nanostructures as ultrasonic molecular reporters. Nat Nanotechnol, 2014, 9(4): 311-6

[57] Ng TSC, Gunda V, Li R, Prytyskach M, Iwamoto Y, Kohler RHet al.. Detecting immune response to therapies targeting PDL1 and BRAF by using ferumoxytol MRI and macrin in anaplastic thyroid cancer. Radiology, 2021, 298(1): 123-32

[58] Xie Z, Hao L, Liu J, Guo C, Jia Q, Wu Set al.. Ph-responsive albumin-mimetic synthetic nanoprobes for magnetic resonance/fluorescence imaging of thyroid cancer. J Biomed Mater Res A, 2024, 112(10): 1712-24

[59] Harisinghani MG, O’Shea A, Weissleder R. Advances in clinical MRI technology. Sci Transl Med, 2019, 11(523 eaba2591

[60] Lee JY, Baek JH, Ha EJ, Sung JY, Shin JH, Kim JH, Lee MK, Jung SL, Lee YH, Ahn HS, Yoon JH, Choi YJ, Park JS, Lee YJ, Choi M, Na DGKorean Society of Thyroid Radiology (KSThR) and Korean Society of Radiology. 2020 imaging guidelines for thyroid nodules and differentiated thyroid cancer: Korean Society of Thyroid Radiology. Korean J Radiol, 2021, 225): 840-860

[61] Schwenck J, Sonanini D, Cotton JM, Rammensee HG, la Fougère C, Zender Let al.. Advances in PET imaging of cancer. Nat Rev Cancer, 2023, 23(7): 474-90

[62] Goel S, England CG, Chen F, Cai W. Positron emission tomography and nanotechnology: a dynamic duo for cancer theranostics. Adv Drug Deliv Rev, 2017, 113: 157-76

[63] Yan Z, Zhang X, Liu Y, Shen Y, Li N, Jia Q, Ji Y, Zhang P, Zhao L, Meng Z. HSA-MnO₂-¹³¹I combined imaging and treatment of anaplastic thyroid carcinoma. Technol Cancer Res Treat, 2022, 21: 15330338221106557

[64] Wang C, Li N, Li Y, Hou S, Zhang W, Meng Zet al.. Engineering a HEK-293T exosome-based delivery platform for efficient tumor-targeting chemotherapy/internal irradiation combination therapy. J Nanobiotechnol, 2022, 20(1 247

[65] Zhang YL, Wang JD, Zhou Z. Experimental study of cervical lymph node in thyroid by using radioactive nano tracer. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, 2010, 4510): 849-53

[66] Fan Y, Xiong Y, Wang X, Chen J, Fang D, Huang Jet al.. Poly (lactic-co-glycolic acid)-encapsulated iodine-131 nanoparticles fabricated with rhTSH induce apoptosis and immobilization of thyroid cancer cells. Front Oncol, 2023, 13 1030105

[67] Chen P, Cai X, Mu G, Duan Y, Jing C, Yang Zet al.. Supramolecular nanofibers co-loaded with dabrafenib and doxorubicin for targeted and synergistic therapy of differentiated thyroid carcinoma. Theranostics, 2023, 13(7): 2140-53

[68] Iqbal A, Rehman A. Thyroid uptake and scan. In: StatPearls. StatPearls Publishing; 2022

[69] Holzinger M, Le Goff A, Cosnier S. Nanomaterials for biosensing applications: a review. Front Chem, 2014, 2 63

[70] Channabasavana Hundi Puttaningaiah KP. Innovative carbonaceous materials and metal/metal oxide nanoparticles for electrochemical biosensor applications. Nanomaterials, 2024, 14(23 1890

[71] Parsa H, Maghsoudi LH, Koohfar S. Investigation of the quality of life and postoperative complications in patients undergoing surgery due to papillary thyroid carcinoma. Indian J Surg Oncol, 2025

[72] Xu S, Li Z, Xu M, Peng H. The role of carbon nanoparticle in lymph node detection and parathyroid gland protection during thyroidectomy for non-anaplastic thyroid carcinoma- a meta-analysis. PLoS One, 2020, 1511 e0223627

[73] Huang S, Zhang L, Xu M, Li C, Fu H, Huang J, Jin X, Liang S, Wang H. Co-delivery of ¹³¹I and Prima-1 by self-assembled CD44-targeted nanoparticles for anaplastic thyroid carcinoma theranostics. Adv Healthc Mater, 2021, 103): e2001029

[74] Sun G, Wang T, Li X, Li D, Peng Y, Wang Xet al.. Sub-Micrometer Au@PDA-¹²⁵ I particles as theranostic embolism beads for radiosensitization and SPECT/CT monitoring. Adv Healthc Mater, 2018, 716 e1800375

[75] Liu Y, Gunda V, Zhu X, Xu X, Wu J, Askhatova Det al.. Theranostic near-infrared fluorescent nanoplatform for imaging and systemic siRNA delivery to metastatic anaplastic thyroid cancer. Proc Natl Acad Sci U S A, 2016, 113287750-5

[76] McDermott MT. Hypothyroidism. Ann Intern Med, 2020, 173(1): ITC1-ITC16

[77] Karabıyık Acar Ö, Bozdağ G, Hacıhasanoğlu E, Tuncer AA, Aysan E, Torun Köse G. Optimizing decellularization protocols for human thyroid tissues: a step towards tissue engineering and transplantation. Biomed Mater, 2024

[78] Khizar S, Alrushaid N, Alam Khan F, Zine N, Jaffrezic-Renault N, Errachid Aet al.. Nanocarriers based novel and effective drug delivery system. Int J Pharm, 2023, 632 122570

[79] Chen W, Huang L, Zhou B. Gold nanourchin on multiple-point dielectrode for glucose biosensing by current-potential measurement. Biotechnol Appl Biochem, 2024, 71(6): 1262-71

[80] Chen C, Wang J. Optical biosensors: an exhaustive and comprehensive review. Analyst, 2020, 145(5): 1605-28

[81] Omer WE, El-Kemary MA, Elsaady MM, Abou-Omar MN, Youssef AO, Sayqal AAet al.. Highly efficient gold nano-flower optical biosensor doped in a sol-gel/PEG matrix for the determination of a calcitonin biomarker in different serum samples. ACS Omega, 2020, 5(11): 5629-37

[82] Quero G, Consales M, Severino R, Vaiano P, Boniello A, Sandomenico Aet al.. Long period fiber grating nano-optrode for cancer biomarker detection. Biosens Bioelectron, 2016, 80: 590-600

[83] Paziani S, Quero G, Managò S, Zito G, Terracciano D, Macchia PE, Galeotti F, Pisco M, De Luca AC, Cusano A. SERS assisted sandwich immunoassay platforms for ultrasensitive and selective detection of human Thyroglobulin. Biosens Bioelectron, 2023, 233: 115322

[84] Kim HM, Jeong DH, Lee HY, Park JH, Lee SK. Design and validation of fiber optic localized surface plasmon resonance sensor for thyroglobulin immunoassay with high sensitivity and rapid detection. Sci Rep, 2021, 11(1 15985

[85] Xu W, Wang D, Li D, Liu CC. Recent developments of electrochemical and optical biosensors for antibody detection. Int J Mol Sci, 2019, 211 134

[86] Sivakumar R, Lee NY. Recent advances in airborne pathogen detection using optical and electrochemical biosensors. Anal Chim Acta, 2022, 1234 340297

[87] Zhang A, Lieber CM. Nano-bioelectronics. Chem Rev, 2016, 1161): 215-57

[88] Beitollahi H, Ivari SG, Torkzadeh-Mahani M. Application of antibody-nanogold-ionic liquid-carbon paste electrode for sensitive electrochemical immunoassay of thyroid-stimulating hormone. Biosens Bioelectron, 2018, 110: 97-102

[89] Park S, Kim J, Kim S, Kim G, Lee NS, Yoon YHet al.. Combined signal amplification using a propagating cascade reaction and a redox cycling reaction for sensitive thyroid-stimulating hormone detection. Anal Chem, 2019, 91(12): 7894-901

[90] Kashefi-Kheyrabadi L, Koyappayil A, Kim T, Cheon YP, Lee MH. A MoS₂@Ti₃C₂T_x MXene hybrid-based electrochemical aptasensor (MEA) for sensitive and rapid detection of thyroxine. Bioelectrochemistry, 2021, 137 107674

[91] Chang T, Yin H, Yu X, Wang L, Fan L, Xin JHet al.. 3D PCL/collagen nanofibrous medical dressing for one-time treatment of diabetic foot ulcers. Colloids and Surfaces B: Biointerfaces, 2022, 214 112480

[92] Serna JA, Rueda-Gensini L, Céspedes-Valenzuela DN, Cifuentes J, Cruz JC, Muñoz-Camargo C. Recent advances on stimuli-responsive hydrogels based on tissue-derived ECMs and their components: towards improving functionality for tissue engineering and controlled drug delivery. Polymers (Basel), 2021, 13(19 3263

[93] Bialek J, Kunanuvat U, Hombach-Klonisch S, Spens A, Stetefeld J, Sunley Ket al.. Relaxin enhances the collagenolytic activity and in vitro invasiveness by upregulating matrix metalloproteinases in human thyroid carcinoma cells. Mol Cancer Res, 2011, 96): 673-87

[94] Okkelman IA, McGarrigle R, O’Carroll S, Berrio DC, Schenke-Layland K, Hynes Jet al.. Extracellular Ca²⁺-sensing fluorescent protein biosensor based on a collagen-binding domain. ACS Appl Bio Mater, 2020, 3(8): 5310-21

[95] Li J, Mei H, Zheng W, Pan P, Sun XJ, Li Fet al.. A novel hydrogen peroxide biosensor based on hemoglobin-collagen-CNTs composite nanofibers. Colloids and Surfaces B: Biointerfaces, 2014, 118: 77-82

[96] Kumar P, Rajan R, Upadhyaya K, Behl G, Xiang XX, Huo Pet al.. Metal oxide nanomaterials based electrochemical and optical biosensors for biomedical applications: recent advances and future prospectives. Environ Res, 2024, 247 118002

[97] Hahn MA, Singh AK, Sharma P, Brown SC, Moudgil BM. Nanoparticles as contrast agents for in-vivo bioimaging: current status and future perspectives. Anal Bioanal Chem, 2011, 399(1): 3-27

[98] Karlas A, Pleitez MA, Aguirre J, Ntziachristos V. Optoacoustic imaging in endocrinology and metabolism. Nat Rev Endocrinol, 2021, 17(6): 323-35

[99] Han X, Xu K, Taratula O, Farsad K. Applications of nanoparticles in biomedical imaging. Nanoscale, 2019, 11(3): 799-819

[100] Ding H, Tan P, Fu S, Tian X, Zhang H, Ma Xet al.. Preparation and application of pH-responsive drug delivery systems. J Control Release, 2022, 348: 206-38

[101] Fan T, Zhu W, Kong M, Yang X, Wang C, Wang Met al.. The significance of PAX8-PPARγ expression in thyroid cancer and the application of a PAX8-PPARγ-targeted ultrasound contrast agent in the early diagnosis of thyroid cancer. Contrast Media Mol Imaging, 2022, 2022 3265342

[102] Hu Z, Yang B, Li T, Li J. Thyroid cancer detection by ultrasound molecular imaging with SHP2-targeted perfluorocarbon nanoparticles. Contrast Media Mol Imaging, 2018, 2018 8710862

[103] Qi M, Gao S, Nie S, Wang K, Guo L. Precise engineering of cetuximab encapsulated gadollium nanoassemblies: in vitro ultrasound diagnosis and in vivo thyroid cancer therapy. Drug Deliv, 2021, 28(1): 569-79

[104] Huynh K, Baghdanian AH, Baghdanian AA, Sun DS, Kolli KP, Zagoria RJ. Updated guidelines for intravenous contrast use for CT and MRI. Emerg Radiol, 2020, 27(2): 115-26

[105] Li T, Wang J, Yang Y, Glide-Hurst CK, Wen N, Cai J. Multi-parametric MRI for radiotherapy simulation. Med Phys, 2023, 50(8): 5273-93

[106] Davies J, Siebenhandl-Wolff P, Tranquart F, Jones P, Evans P. Gadolinium: pharmacokinetics and toxicity in humans and laboratory animals following contrast agent administration. Arch Toxicol, 2022, 96(2): 403-29

[107] Miao Y, Yang T, Yang S, Yang M, Mao C. Protein nanoparticles directed cancer imaging and therapy. Nano Convergence, 2022, 9(1 2

[108] Farzin A, Etesami SA, Quint J, Memic A, Tamayol A. Magnetic nanoparticles in cancer therapy and diagnosis. Adv Healthc Mater, 2020, 99 e1901058

[109] Geraldes CFGC. Manganese oxide nanoparticles for MRI-based multimodal imaging and theranostics. Molecules, 2024, 2923 5591

[110] Tian H, Li Z, Hao Let al.. Preparation and study of MRI targeted probe Gd-DOTA-pertuzumab for thyroid cancer. China Med Equip, 2022, 1912): 171-175

[111] Mandal A, Sekar S, Kanagavel M, Chandrasekaran N, Mukherjee A, Sastry TP. Collagen based magnetic nanobiocomposite as MRI contrast agent and for targeted delivery in cancer therapy. Biochim Biophys Acta, 2013, 1830(10): 4628-33

[112] Shi Y, Guenneau F, Wang X, Hélary C, Coradin T. MnO₂-gated nanoplatforms with targeted controlled drug release and contrast-enhanced MRI properties: from 2D cell culture to 3D biomimetic hydrogels. Nanotheranostics, 2018, 2(4): 403-16

[113] Filetti S, Durante C, Hartl D, Leboulleux S, Locati LD, Newbold Ket al.. Thyroid cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up†. Ann Oncol, 2019, 30(12): 1856-83

[114] Finessi M, Bisi G, Deandreis D. Hyperglycemia and 18F-FDG PET/CT, issues and problem solving: a literature review. Acta Diabetol, 2020, 57(3): 253-62

[115] Wang Y, Li Y, Wei F, Duan Y. Optical imaging paves the way for autophagy research. Trends Biotechnol, 2017, 35(12): 1181-93

[116] Shao C, Li Z, Zhang C, Zhang W, He R, Xu Jet al.. Optical diagnostic imaging and therapy for thyroid cancer. Mater Today Bio, 2022, 17 100441

[117] Wang R, Zhou L, Wang W, Li X, Zhang F. In vivo gastrointestinal drug-release monitoring through second near-infrared window fluorescent bioimaging with orally delivered microcarriers. Nat Commun, 2017, 8 14702

[118] Wang M, Zhang X, Chang Q, Zhang H, Zhang Z, Li Ket al.. Tumor microenvironment-mediated NIR-I-to-NIR-II transformation of Au self-assembly for theranostics. Acta Biomater, 2023, 168: 606-16

[119] Cheng K, Chen H, Jenkins CH, Zhang G, Zhao W, Zhang Zet al.. Synthesis, characterization, and biomedical applications of a targeted dual-modal near-infrared-II fluorescence and photoacoustic imaging nanoprobe. ACS Nano, 2017, 11(12): 12276-91

[120] Sargazi S, Fatima I, Hassan Kiani M, Mohammadzadeh V, Arshad R, Bilal Met al.. Fluorescent-based nanosensors for selective detection of a wide range of biological macromolecules: a comprehensive review. Int J Biol Macromol, 2022, 206: 115-47

[121] Foucault-Collet A, Gogick KA, White KA, Villette S, Pallier A, Collet Get al.. Lanthanide near infrared imaging in living cells with Yb³⁺ nano metal organic frameworks. Proc Natl Acad Sci U S A, 2013, 110(43): 17199-204

[122] Jia Q, Li F, Li C, Guo C, Wu S, Hao Let al.. Human epidermal growth factor receptor 2(Her2)-targeted ph-responsive mr/nirf bimodal imaging-mediated nano-delivery system for the diagnosis and treatment of undifferentiated thyroid cancer. Drug Deliv Transl Res, 2025, 15(6): 2099-115

[123] Sencha LM, Dobrynina OE, Pospelov AD, Guryev EL, Peskova NN, Brilkina AAet al.. Real-time fluorescence visualization and quantitation of cell growth and death in response to treatment in 3D collagen-based tumor model. Int J Mol Sci, 2022, 23(16 8837

[124] Wen Y, Guo D, Zhang J, Liu X, Liu T, Li Let al.. Clinical photoacoustic/ultrasound dual-modal imaging: current status and future trends. Front Physiol, 2022, 13 1036621

[125] Liu H, Wang M, Ji F, Jiang Y, Yang M. Mini review of photoacoustic clinical imaging: a noninvasive tool for disease diagnosis and treatment evaluation. J Biomed Opt, 2024, 29Suppl 1 S11522

[126] Zhang R, Thoröe-Boveleth S, Chigrin DN, Kiessling F, Lammers T, Pallares RM. Nanoscale engineering of gold nanostars for enhanced photoacoustic imaging. J Nanobiotechnol, 2024, 221 115

[127] Nie L, Chen X. Structural and functional photoacoustic molecular tomography aided by emerging contrast agents. Chem Soc Rev, 2014, 4320): 7132-70

[128] Ma X, Li X, Shi J, Yao M, Zhang X, Hou Ret al.. Host-guest polypyrrole nanocomplex for three-stimuli-responsive drug delivery and imaging-guided chemo-photothermal synergetic therapy of refractory thyroid cancer. Adv Healthc Mater, 2019, 8(17 e1900661

[129] Xu M, Zhao D, Chen Y, Chen C, Zhang L, Sun Let al.. Charge reversal polypyrrole nanocomplex-mediated gene delivery and photothermal therapy for effectively treating papillary thyroid cancer and inhibiting lymphatic metastasis. ACS Appl Mater Interfaces, 2022, 1412): 14072-86

[130] Zhang J, Fan Y, He M, Ma X, Song Y, Liu Met al.. Accuracy of raman spectroscopy in differentiating brain tumor from normal brain tissue. Oncotarget, 2017, 8(22): 36824-31

[131] Xu W, Zhu W, Xia Y, Hu S, Liao G, Xu Zet al.. Raman spectroscopy for cell analysis: retrospect and prospect. Talanta, 2025, 285 127283

[132] Zhang Y, Chen R, Liu F, Miao P, Lin L, Ye J. In vivo surface-enhanced transmission raman spectroscopy under maximum permissible exposure: toward photosafe detection of deep-seated tumors. Small Methods, 2023, 7(2): e2201334

[133] Gao L, Wu S, Wongwasuratthakul P, Chen Z, Cai W, Li Qet al.. Label-free surface-enhanced raman spectroscopy with machine learning for the diagnosis of thyroid cancer by using fine-needle aspiration liquid samples. Biosensors, 2024, 148 372

[134] Xia L, Lu J, Chen Z, Cui X, Chen S, Pei D. Identifying benign and malignant thyroid nodules based on blood serum surface-enhanced Raman spectroscopy. Nanomedicine, 2021, 32 102328

[135] Hao RT, Chen J, Zhao LH, Liu C, Wang OC, Huang GLet al.. Sentinel lymph node biopsy using carbon nanoparticles for Chinese patients with papillary thyroid microcarcinoma. Eur J Surg Oncol, 2012, 388718-24

[136] Chen Y, Zhang S, Miao K, Li J. Evaluating the effectiveness of dual dye combination of indocyanine green and carbon nanoparticles with parathyroid hormone test in preserving parathyroid gland during papillary thyroid cancer surgery: a single-center retrospective cohort study. Update Surg, 2024, 76(3): 1063-71

[137] Jović D, Jaćević V, Kuča K, Borišev I, Mrdjanovic J, Petrovic Det al.. The puzzling potential of carbon nanomaterials: general properties, application, and toxicity. Nanomaterials, 2020, 10(8 1508

[138] Madannejad R, Shoaie N, Jahanpeyma F, Darvishi MH, Azimzadeh M, Javadi H. Toxicity of carbon-based nanomaterials: reviewing recent reports in medical and biological systems. Chem Biol Interact, 2019, 307: 206-22

[139] Zheng W, Liu C, Jin J, Sun W, Zhao J, Zhao Met al.. Biodegradable iron oxide nanoparticles for intraoperative parathyroid gland imaging in thyroidectomy. PNAS Nexus, 2022, 13 pgac087

[140] Sorushanova A, Delgado LM, Wu Z, Shologu N, Kshirsagar A, Raghunath R, Mullen AM, Bayon Y, Pandit A, Raghunath M, Zeugolis DI. The collagen suprafamily: from biosynthesis to advanced biomaterial development. Adv Mater, 2019, 311): e1801651

[141] Li L, Sheng Q, Zeng H, Li W, Wang Q, Ma Get al.. Engineering a functional thyroid as a potential therapeutic substitute for hypothyroidism treatment: a systematic review. Front Endocrinol, 2022, 13 1065410

[142] Toda S, Koike N, Sugihara H. Thyrocyte integration, and thyroid folliculogenesis and tissue regeneration: perspective for thyroid tissue engineering. Pathol Int, 2001, 516403-17

[143] Li L, Sheng Q, Zeng H, Li W, Wang Q, Ma Get al.. Engineering a functional thyroid as a potential therapeutic substitute for hypothyroidism treatment: a systematic review. Front Endocrinol, 2022, 13 1065410

[144] Bulanova EA, Koudan EV, Degosserie J, Heymans C, Pereira FD, Parfenov VAet al.. Bioprinting of a functional vascularized mouse thyroid gland construct. Biofabrication, 2017, 9(3 034105

[145] Patra JK, Das G, Fraceto LF, Campos EVR, Rodriguez-Torres MDP, Acosta-Torres LSet al.. Nano based drug delivery systems: recent developments and future prospects. J Nanobiotechnol, 2018, 161 71

[146] Leporatti S. Thinking about enhanced permeability and retention effect (EPR). J Pers Med, 2022, 128 1259

[147] Huang P, Tang N, Mao LF, Zhang Y, Tang XF, Zhou RYet al.. Nanoclay drug-delivery system loading potassium iodide promotes endocytosis and targeted therapy in anaplastic thyroid cancer. Nano Lett, 2023, 2317): 8013-21

[148] Zhang L, Zhu C, Huang S, Xu M, Li C, Fu Het al.. Efficient delivery of anlotinib and radioiodine by long circulating nano-capsules for active enhanced suppression of anaplastic thyroid carcinoma. J Nanobiotechnol, 2025, 23(1 180

[149] Sindhwani S, Syed AM, Ngai J, Kingston BR, Maiorino L, Rothschild Jet al.. The entry of nanoparticles into solid tumours. Nat Mater, 2020, 195): 566-75

[150] Kingston BR, Lin ZP, Ouyang B, MacMillan P, Ngai J, Syed AMet al.. Specific endothelial cells govern nanoparticle entry into solid tumors. ACS Nano, 2021, 15(9): 14080-94

[151] Challenging paradigms in tumour drug delivery. Nat Mater. 2020;19:477. https://doi.org/10.1038/s41563-020-0676-x

[152] Izci M, Maksoudian C, Manshian BB, Soenen SJ. The use of alternative strategies for enhanced nanoparticle delivery to solid tumors. Chem Rev, 2021, 121(3): 1746-803

[153] de Lázaro I, Mooney DJ. A nanoparticle’s pathway into tumours. Nat Mater, 2020, 19(5): 486-7

[154] Petersen GH, Alzghari SK, Chee W, Sankari SS, La-Beck NM. Meta-analysis of clinical and preclinical studies comparing the anticancer efficacy of liposomal versus conventional non-liposomal doxorubicin. J Control Release Off J Control Release Soc, 2016, 232: 255-64

[155] Fujimoto I, Takei Y. Atelocollagen-mediated siRNA delivery: future promise for therapeutic application. Ther Deliv, 2014, 5(4): 369-71

[156] Inaba S, Nagahara S, Makita N, Tarumi Y, Ishimoto T, Matsuo Set al.. Atelocollagen-mediated systemic delivery prevents immunostimulatory adverse effects of siRNA in mammals. Mol Ther, 2012, 20(2): 356-66

[157] Takeshita F, Minakuchi Y, Nagahara S, Honma K, Sasaki H, Hirai Ket al.. Efficient delivery of small interfering RNA to bone-metastatic tumors by using atelocollagen in vivo. Proc Natl Acad Sci U S A, 2005, 102(34): 12177-82

[158] Umebayashi M, Sumita Y, Kawai Y, Watanabe S, Asahina I. Gene-activated matrix comprised of atelocollagen and plasmid DNA encoding BMP4 or Runx2 promotes rat cranial bone augmentation. Biores Open Access, 2015, 4(1): 164-74

[159] Yadav P, Singh SP, Rengan AK, Shanavas A, Srivastava R. Gold laced bio-macromolecules for theranostic application. Int J Biol Macromol, 2018, 110: 39-53

[160] Suarasan S, Simon T, Boca S, Tomuleasa C, Astilean S. Gelatin-coated gold nanoparticles as carriers of FLT3 inhibitors for acute myeloid leukemia treatment. Chem Biol Drug Des, 2016, 87(6): 927-35

[161] Wu BB, Leung KT, Poon EN. Mitochondrial-targeted therapy for doxorubicin-induced cardiotoxicity. Int J Mol Sci, 2022, 23(3 1912

[162] Koppolu B, Bhavsar Z, Wadajkar AS, Nattama S, Rahimi M, Nwariaku Fet al.. Temperature-sensitive polymer-coated magnetic nanoparticles as a potential drug delivery system for targeted therapy of thyroid cancer. J Biomed Nanotechnol, 2012, 86): 983-90

[163] Marano F, Frairia R, Rinella L, Argenziano M, Bussolati B, Grange Cet al.. Combining doxorubicin-nanobubbles and shockwaves for anaplastic thyroid cancer treatment: preclinical study in a xenograft mouse model. Endocr Relat Cancer, 2017, 24(6): 275-86

[164] Chen MM, Huang YQ, Cao H, Liu Y, Guo H, Chen LSet al.. Collagen/chitosan film containing biotinylated glycol chitosan nanoparticles for localized drug delivery. Colloids Surf, B, 2015, 128: 339-46

[165] Park J, Kim JS, Yang G, Lee H, Shim G, Lee Jet al.. Lysyl oxidase-responsive anchoring nanoparticles for modulation of the tumor immune microenvironment. J Control Release, 2023, 360: 376-91

[166] Cho SH, Kim A, Shin W, Heo MB, Noh HJ, Hong KS, Cho JH, Lim YT. Photothermal-modulated drug delivery and magnetic relaxation based on collagen/poly(γ-glutamic acid) hydrogel. Int J Nanomed, 2017, 12: 2607-2620

[167] Javidan B, Gharbani P. Synthesis of copper hexaferrite magnetic nanoparticles based on carboxymethyl cellulose modified with polyacrylic acid (CMC/PAA/CuFe₁₂O₁₉) for loading and release of Levothyroxine. Int J Biol Macromol, 2024, 282(Pt 3): 137040

[168] Wang B, Yin Z, You X, Peng H, Jiang Y. Thyroid-targeted nano-bombs empower HIFU for Graves' disease. Adv Sci, 2025, 1211e2414597

[169] Sedger LM, Seddiki N, Ranasinghe C. Cytokines and cytokine receptors as immunotherapeutics: humble beginnings and exciting futures. Cytokine Growth Factor Rev, 2014, 254351-3

[170] Revilla G, Al Qtaish N, Caruana P, Sainz-Ramos M, Lopez-Mendez T, Rodriguez Fet al.. Lenvatinib-loaded poly(lactic-co-glycolic acid) nanoparticles with epidermal growth factor receptor antibody conjugation as a preclinical approach to therapeutically improve thyroid cancer with aggressive behavior. Biomolecules, 2023, 13(11 1647

[171] Xiong L, Lin XM, Nie JH, Ye HS, Liu J. Resveratrol and its nanoparticle suppress Doxorubicin/Docetaxel-resistant anaplastic thyroid cancer cells in vitro and in vivo. Nanotheranostics, 2021, 52): 143-54

[172] Nawaz FZ, Kipreos ET. Emerging roles for folate receptor FOLR1 in signaling and cancer. Trends Endocrinol Metab, 2022, 33(3): 159-74

[173] Niemelä E, Desai D, Niemi R, Doroszko M, Özliseli E, Kemppainen Ket al.. Nanoparticles carrying fingolimod and methotrexate enables targeted induction of apoptosis and immobilization of invasive thyroid cancer. Eur J Pharm Biopharm, 2020, 148: 1-9

[174] Ren Y, Yan Y, Qi H. Photothermal conversion and transfer in photothermal therapy: from macroscale to nanoscale. Adv Colloid Interface Sci, 2022, 308 102753

[175] Chen J, Ning C, Zhou Z, Yu P, Zhu Y, Tan Get al.. Nanomaterials as photothermal therapeutic agents. Prog Mater Sci, 2019, 99: 1-26

[176] Cheng L, Wang C, Feng L, Yang K, Liu Z. Functional nanomaterials for phototherapies of cancer. Chem Rev, 2014, 114(21): 10869-939

[177] Du C, Wu X, He M, Zhang Y, Zhang R, Dong CM. Polymeric photothermal agents for cancer therapy: recent progress and clinical potential. J Mater Chem B, 2021, 9(6): 1478-90

[178] Jung HS, Verwilst P, Sharma A, Shin J, Sessler JL, Kim JS. Organic molecule-based photothermal agents: an expanding photothermal therapy universe. Chem Soc Rev, 2018, 47(7): 2280-97

[179] Huang Y, Zeng G, Xin Q, Yang J, Zeng C, Tang Ket al.. Carbon nanoparticles suspension injection for photothermal therapy of xenografted human thyroid carcinoma in vivo. MedComm, 2020, 1(2): 202-10

[180] Yu T, Tong L, Ao Y, Zhang G, Liu Y, Zhang H. Novel design of NIR-triggered plasmonic nanodots capped mesoporous silica nanoparticles loaded with natural capsaicin to inhibition of metastasis of human papillary thyroid carcinoma B-CPAP cells in thyroid cancer chemo-photothermal therapy. J Photochem Photobiol B-Biol, 2019, 197 111534

[181] Yang XZ, Wen LF, Xu G, Lin HH, Wang S, Liu JY. Multifunctional organic nanomaterials with ultra-high photothermal conversion efficiency for photothermal therapy and inhibition of cancer metastasis. Bioorg Chem, 2023, 130 106220

[182] Hwang J, An EK, Zhang W, Kim HJ, Eom Y, Jin JO. Dual-functional alginate and collagen-based injectable hydrogel for the treatment of cancer and its metastasis. J Nanobiotechnol, 2022, 20(1 245

[183] Guidolin K, Ding L, Yan H, Englesakis Hba M, Chadi S, Quereshy Fet al.. Photodynamic therapy for colorectal cancer: a systematic review of clinical research. Surg Innov, 2022, 296): 788-803

[184] Liang S, Deng X, Ma P, Cheng Z, Lin J. Recent advances in nanomaterial-assisted combinational sonodynamic cancer therapy. Adv Mater, 2020, 32(47): e2003214

[185] Alvarez N, Sevilla A. Current advances in photodynamic therapy (PDT) and the future potential of PDT-combinatorial cancer therapies. Int J Mol Sci, 2024, 252 1023

[186] Zhang C, Pu K. Organic sonodynamic materials for combination cancer immunotherapy. Adv Mater, 2023, 3551e2303059

[187] Yang D, Lei S, Pan K, Chen T, Lin J, Ni Get al.. Application of photodynamic therapy in immune-related diseases. Photodiagn Photodyn Ther, 2021, 34 102318

[188] Yang F, Lv J, Ma W, Yang Y, Hu X, Yang Z. Engineering sonosensitizer-derived nanotheranostics for augmented sonodynamic therapy. Small, 2024, 2044e2402669

[189] Zhang S, Yang N, Sun S, Zhao H, Wang W, Nie Jet al.. Dually fluorinated unimolecular micelles for stable oxygen-carrying and enhanced photosensitive efficiency to boost photodynamic therapy against hypoxic tumors. Acta Biomater, 2025, 193: 406-16

[190] Gong Z, Dai Z. Design and challenges of sonodynamic therapy system for cancer theranostics: from equipment to sensitizers. Adv Sci, 2021, 8(10 2002178

[191] Sun J, Kormakov S, Liu Y, Huang Y, Wu D, Yang Z. Recent progress in metal-based nanoparticles mediated photodynamic therapy. Molecules, 2018, 237 1704

[192] Wang C, Xiong C, Li Z, Hu L, Wei J, Tian J. Defect-engineered porphyrinic metal-organic framework nanoparticles for targeted multimodal cancer phototheranostics. Chem Commun (Camb), 2021, 5733): 4035-8

[193] Feng Y, Jiang Q, Ma X, Sun H, Chai Y, Li Xet al.. Photosensitizing metal-organic framework nanoparticles combined with tumor-sensitization strategies can enhance the phototherapeutic effect upon medullary thyroid carcinoma. Biochim Biophys Acta, 2024, 1868(12 130725

[194] Guan S, Teng D, Wang H, Wang Q, Zhen X, Sui G, Wang Y, Zhu L, Lin Y, Jiao D, Guo F. Multifunctional phase-transition nanoparticles for effective targeted sonodynamic-gene therapy against thyroid papillary carcinoma. Int J Nanomed, 2023, 18: 2275-2293

[195] Ain QT. Recent development of nanomaterials-based PDT to improve immunogenic cell death. Photochem Photobiol Sci, 2024, 2310): 1983-98

[196] Zhou J, Ma L, Li Z, Chen B, Wu Y, Meng X. Synthesis of lenvatinib-loaded upconversion@polydopamine nanocomposites for upconversion luminescence imaging-guided chemo-photothermal synergistic therapy of anaplastic thyroid cancer. RSC Adv, 2023, 13(38): 26925-32

[197] Xing R, Liu K, Jiao T, Zhang N, Ma K, Zhang Ret al.. An injectable self-assembling collagen-gold hybrid hydrogel for combinatorial antitumor photothermal/photodynamic therapy. Adv Mater, 2016, 28(19): 3669-76

[198] Sun X, Xing L, Ling CC, Li GC. The effect of mild temperature hyperthermia on tumour hypoxia and blood perfusion: relevance for radiotherapy, vascular targeting and imaging. Int J Hyperthermia Off J Eur Soc Hyperthermic Oncol N Am Hyperthermia Group, 2010, 26(3): 224-31

[199] Tecchio C, Colato C, Bonifacio M, Krampera M, Maluta S, Pizzolo Get al.. Plasmacytoid dendritic cell leukemia: a rapidly evolving disease presenting with skin lesions sensitive to radiotherapy plus hyperthermia. Oncologist, 2009, 14(12): 1205-8

[200] Zhou M, Chen Y, Adachi M, Wen X, Erwin B, Mawlawi Oet al.. Single agent nanoparticle for radiotherapy and radio-photothermal therapy in anaplastic thyroid cancer. Biomaterials, 2015, 57: 41-9

[201] Sun T, Dou JH, Liu S, Wang X, Zheng X, Wang Yet al.. Second near-infrared conjugated polymer nanoparticles for photoacoustic imaging and photothermal therapy. ACS Appl Mater Interfaces, 2018, 10(9): 7919-26

[202] Huang S, Wu Y, Li C, Xu L, Huang J, Huang Yet al.. Tailoring morphologies of mesoporous polydopamine nanoparticles to deliver high-loading radioiodine for anaplastic thyroid carcinoma imaging and therapy. Nanoscale, 2021, 13(35): 15021-30

[203] Wang Q, Sui G, Wu X, Teng D, Zhu L, Guan Set al.. A sequential targeting nanoplatform for anaplastic thyroid carcinoma theranostics. Acta Biomater, 2020, 102: 367-83

[204] Zhao J, Wang J, Cheng R, Qin J, Ai Z, Sun Het al.. Safety and effectiveness of carbon nanoparticles suspension-guided lymph node dissection during thyroidectomy in patients with thyroid papillary cancer: a prospective, multicenter, randomized, blank-controlled trial. Front Endocrinol, 2024, 14 1251820

[205] Koimtzis G, Stefanopoulos L, Alexandrou V, Tteralli N, Brooker V, Alawad AAet al.. The role of carbon nanoparticles in lymph node dissection and parathyroid gland preservation during surgery for thyroid cancer: a systematic review and meta-analysis. Cancers (Basel), 2022, 14(16 4016

[206] Huang Y, Hsu JC, Koo H, Cormode DP. Repurposing ferumoxytol: diagnostic and therapeutic applications of an FDA-approved nanoparticle. Theranostics, 2022, 122): 796-816

[207] Mohammed RS, Aadim KA, Ahmed KA. Histological, haematological, and thyroid hormones toxicity of female rats orally exposed to CuO/ZnO core/shell nanoparticles synthesized by Ar plasma jets. Arch Toxicol, 2023, 97(4): 1017-31

[208] Anchordoquy T, Artzi N, Balyasnikova IV, Barenholz Y, La-Beck NM, Brenner JSet al.. Mechanisms and barriers in nanomedicine: progress in the field and future directions. ACS Nano, 2024, 18(22): 13983-99

Funding

West China Hospital, Sichuan University(No. ZYJC21033)

RIGHTS & PERMISSIONS

The Author(s)